Skip to main content
. 2017 Oct 5;7:12711. doi: 10.1038/s41598-017-12637-4

Table 1.

Description of the patients involved in the outbreak.

Case number Age bracket Speciality at admission Specimen of first isolate Subsequent clinical isolate (n days between screen and clinical isolate)a Any antibiotic therapy prior to identification of NDM infectionb CPE antibiotic therapy used post NDM identification Initial colistin MIC (mg/L)c Highest colistin MIC (mg/L)d Colistin resistant at any stage
KP_NDM1 81–90 Renal Urine Amikacin No antibiotics <0.05 8 Yes
KP_NDM2 51–60 Vascular Screening Liver abscess (5) Amikacin Metronidazole Piperacillin/Tazobactam Vancomycin Colistimethate sodium Tigecycline <0.05 16 Yes
KP_NDM3 81–90 Orthopaedic Urine None identified No antibiotics <0.05
KP_NDM4 61–70 Renal Abdominal fluid Ciprofloxacin Meropenem Metronidazole Piperacillin/Tazobactam Vancomycin No antibiotics <0.05 1
KP_NDM5 51–60 Vascular Urine None identified No antibiotics <0.05
KP_NDM6 61–70 Cardiac Wound (Leg) Meropenem Colistimethate sodium Tigecycline Not done <0.05
KP_NDM7 71–80 Renal Screening Leg swab and tissue, urine (22) None identified Colistimethate sodium Tigecycline 4 8 Yes
KP_NDM8 71–80 Vascular Screening None None identified No antibiotics 32 Yes
KP_NDM9 71–80 Renal Screening Urine, central veneous catheter tip (4) Meropenem Colistimethate sodium Tigecycline, 8 Yes
KP_NDM10 71–80 Renal Screening None Nystatina No antibiotics <0.05
KP_NDM11 81–90 Cardiac Screening None None identified Colistimethate sodium Tigecycline 32 Yes
KP_NDM12 61–70 Renal Screening and urine Cotrimoxazoled Colistimethate sodium Tigecycline 8 8 Yes
KP_NDM13 61–70 Cardiac Screening None None identified No antibiotics 8 Yes
KP_NDM14 81–90 Cardiac Screening None Cefalexin No antibiotics Not available
KP_NDM15 61–70 Cardiac Screening None Amikacin Clarithromycin Co–amoxiclav Piperacillin/Tazobactam Vancomycin No antibiotics <0.05
KP_NDM16 81–90 Renal Screening Groin wound swab (16) Meropenem Tigecycline 8 Yes
KP_NDM17 71–80 Renal Screening Urine and mouth ulcers (235) Co–amoxiclav Piperacillin/Tazobactam Vancomycin Tigecycline 16 Yes
KP_NDM18 51–60 Renal Screening None Ciprofloxacin Cotrimoxazoled Metronidazole Piperacillin/Tazobactam, Vancomycin, No antibiotics 32 Yes
KP_NDM19 81–90 Renal Screening Urine (6) Meropenem Tigecycline <0.5
KP_NDM20 71–80 Renal Screening Wound swab (11) None identified No antibiotics <0.5 >32 Yes
KP_NDM21 51–60 Renal Screening Urine (15) None identified No antibiotics 1
KP_NDM22 61–70 Renal Screening Urine (254) None identified No antibiotics Not done
KP_NDM23 61–70 Vascular Wound (surgical) Ciprofloxacin, Vancomycin No antibiotics 32 16 Yes
KP_NDM24 61–70 Cardiac Screening None Co-amoxiclav Ciprofloxacin Vancomycin No antibiotics 4 Yes
KP_NDM25 71–80 Intensive Care Screening Wound swabs (groin and thigh) (28) Metronidazole Piperacillin/Tazobactam Vancomycin Colistimethate sodium Tigecycline 4 Yes
KP_NDM26 61–70 Renal Screening None Piperacillin/Tazobactam, Vancomycin No antibiotics 16 Yes
KP_NDM27 21–30 Intensive Care Screening None Co-trimoxazoled Valganciclovird No antibiotics 16 Yes
KP_NDM28 31–40 Intensive Care Screening None Amikacin Linezolid Liposomal amphotericin, No antibiotics 4 Yes
KP_NDM29 71–80 Vascular Soft tissue and bone (foot) Amikacin Piperacillin/ Tazobactam, Vancomycin, No antibiotics 8 2 Yes
KP_NDM30 61–70 Cardiac Screening None Ceftriaxone Colistimethate sodium Tigecycline 1
KP_NDM31 81–90 Emergency Medicine Screening Urine (3) Ceftriaxone Flucloxacillin Gentamycin, Metronidazole Rifampicin No antibiotics 8 Yes
KP_NDM32 51–60 Maternity Screening Urine (18) Amikacin, Caspofungin Co-trimoxazoledd Ciprofloxacin Metronidazole, Vancomycin No antibiotics 8 8 Yes
KP_NDM33 51–60 Intensive Care Screening Central veneous catheter tip, abdominal wound (5) Co-trimoxazoled Meropenem, Nystatind No antibiotics 8 Yes
KP_NDM34 21–30 Renal Screening None Piperacillin/Tazobactam No antibiotics 16 Yes
KP_NDM35 51–60 Renal Soft tissue and bone (foot) Ciprofloxacin, Clindamycin Vancomycin, Colistimethate sodium, Tigecycline <0.5
KP_NDM36 61–70 Vascular Screening None Anidulanfungin Meropene Rifaximin Vancomycin No antibiotics <0.5
KP_NDM37 91–100 Vascular Screening None Ceftriaxone No antibiotics <0.5
KP_NDM38 0–10 Vascular Screening None Benzylpenicillin Colistimethate sodium, Gentamicin No antibiotics 8 Yes
KP_NDM39 51–60 Vascular Screening None None identified Colistimethate sodium, Tigecycline <0.5
KP_NDM40 61–70 Vascular Screening None Isoniazidd No antibiotics 8 Yes

aColumn denotes patients who were initially identified by screening, but had a subsequent clinical isolate, the site of the first clinical isolate, and the time between the screen and the first clinical isolate.

bIdentified through case note review/electronic pharmacy records for period 2014/15.

cBold font denotes colistin resistance (>2 mg/L).

dProphylaxis post-transplant as part of approved protocols.